1 / 11

Diabetes Devices and Drugs:North America Guides Global Market at a 5.9% CAGR from 2013 to 2019

<br>Diabetes is a chronic metabolic disease wherein the body is either not able to produce insulin (type-1) or is not able to utilize the generated insulin (type-2). This elevated sugar level leads to various symptoms such as increased thirst, weight loss, high appetite, frequent and sweet smelled urination. If untreated, diabetes causes various acute and chronic life-threatening complications. This report studies the current as well as future scenario of the diabetes diagnostic devices and drugs market globally.

kksingha
Download Presentation

Diabetes Devices and Drugs:North America Guides Global Market at a 5.9% CAGR from 2013 to 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Transparency Market Research Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 Published Date 01-July-2014 208 Page Report Request Sample Buy Now Press Release Diabetes Devices and Drugs: North America Guides Global Market at a 5.9% CAGR from 2013 to 2019:Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com

  2. Diabetes Device And Drugs Market REPORT DESCRIPTION Diabetes Devices and Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 Diabetes is a chronic metabolic disease wherein the body is either not able to produce insulin (type-1) or is not able to utilize the generated insulin (type-2). This elevated sugar level leads to various symptoms such as increased thirst, weight loss, high appetite, frequent and sweet smelled urination. If untreated, diabetes causes various acute and chronic life- threatening complications. This report studies the current as well as future scenario of the diabetes diagnostic devices and drugs market globally. Browse Full Report With TOC:- http://www.transparencymarketresearch.com/diabetes-devices-market.html The diabetes diagnostic devices and drugs market has been segmented based on devices and drugs available for the treatment the disease. Based on device type, the market is segmented into diabetes diagnostic devices and insulin delivery devices. Diabetes diagnostic devices include analog blood meter, test strips, lancets and lancing devices, continuous glucose monitoring devices and others. The insulin delivery devices segment include insulin syringes, insulin pens, insulin pumps and insulin injectors. Based on drugs, the market is segmented into insulin derivatives, oral anti-diabetes drugs and non-insulin injectable anti- diabetes drugs. The insulin derivatives segment is further categorized as rapid-acting, short-acting, intermediate-acting, long-acting and premixed insulin derivatives. The oral anti-diabetes drugs segment includes various drugs classes such as sulphonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors, GPP-4 inhibitors and SGLT-2 inhibitors. The non-insulin injectable anti-diabetes drugs segment is segmented into GLP-1 analogs and Pramlintide. The market for these devices and drugs has been extensively analyzed based on demand for branded and generic products in each class of drugs and devices. Rising prevalence of diabetic population across various regions of the world, pipeline products from each class, rising preference of patients and healthcare professionals toward technologically advanced monitoring and insulin delivery devices is driving the growth of the diabetes diagnostic devices and drugs market. Related & Recently Published Report by Transparency Market Research Biological Drugs Market :- http://www.transparencymarketresearch.com/biological-drugs-market.html The market size and forecasts in terms of revenue (USD million) for each of these segments have been provided for the period 2013 to 2019, considering 2012 as the base year. The diabetes devices and drugs market report also provides the compounded annual growth rate (CAGR) for each segment of the market for the forecast period 2013 to 2019. Geographically, the diabetes diagnostic devices and drugs market has been segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). The market size and forecast for each region has been 2 Transparency Market Research

  3. Diabetes Device And Drugs Market provided for the period 2011 to 2019, along with the CAGR (%) for the forecast period 2013 to 2019. The diabetes diagnostic devices and drugs market study also includes qualitative analysis of the competitive scenario in these regions. The market overview section of the report comprises a qualitative analysis of the overall market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s five forces analysis and market attractiveness analysis. In addition, thorough analyses of various events, which occurred in the past five years and are expected to occur during forecast period, are also provided in the market overview section of the report. In this section, the major events, which affected the market and are expected to affect the market are studied. Further, value chain analysis (VCA) for drugs and devices is also provided, which highlights the major stages of the development of drugs and devices. The entire section of market overview plays an important role in understanding the market on a global level. Browse Press Release Of This Report:- http://www.transparencymarketresearch.com/pressrelease/diabetes- devices-market.htm The diabetes devices and drugs market report also provides a highlight of the competitive landscape of the market wherein the market share analysis of the leading players in the diabetes devices and drugs market, in terms of percentage share in 2012 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the market and accentuate market shares. The report concludes with the profiles of major players in the diabetes devices and drugs market such as Abbott Laboratories, Inc., AstraZeneca plc, B Braun Melsungen AG, Bayer HealthCare AG, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, DexCom, Inc., Eli Lilly and Company, F. Hoffmann La-Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Lupin Limited, Medtronic, Inc., Merck & Co., Inc., Novartis International AG, Novo Nordisk A/S, Sanofi, and Takeda Pharmaceutical Company Limited. Market players are profiled based on attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments. Browse Article Of This Report:- http://www.transparencymarketresearch.com/article/diabetes-devices-market.htm The global diabetes devices and drugs market is segmented into the following categories:  Global Diabetes Devices Market, by Devices  Diabetes Monitoring and diagnostic devices  Analog glucose meter  Glucose Test strips  Lancets and Lancing devices  Continuous glucose monitoring devices  Others 3 Transparency Market Research

  4. Diabetes Device And Drugs Market  Insulin Delivery Devices  Insulin Syringes  Insulin Pens  Insulin Pumps  Insulin Injectors  Global Diabetes Drugs Market, by Therapy  Insulin  Short-acting insulin derivatives  Intermediate-acting insulin derivatives  Long-acting insulin derivatives  Rapid-acting insulin derivatives  Premixed insulin derivatives  Oral anti-diabetes drugs class  Sulphonylureas  Biguanides  Meglitinides  Thiazolidinediones  Alpha-glucosidase inhibitors  DPP-4 inhibitors  SGLT-2 inhibitors  Non-insulin injectable anti-diabetes drugs  GLP-1 analogs  Global Diabetes Drugs Market, by Geography  North America  Europe  Asia-Pacific 4 Transparency Market Research

  5. Diabetes Device And Drugs Market  Rest of the World (RoW) Get Sample Report Copy with TOC and Market Research : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14 TABLE OF CONTENT Chapter 1 Introduction 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology Chapter 2 Executive Summary 2.1 Market Snapshot: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease 2.2 Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography, 2013 & 2020 (Value %) Chapter 3 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease Overview 3.1 Introduction 3.2 Market Drivers 3.2.1 Rapidly Aging Population Leading to Rising Risk and High Prevalence of Neurological Disorders such as Parkinson’s disease, Alzheimer’s disease, Dementia, etc. 3.2.2 Growing Demand for Deep Brain Stimulation Devices due to Rising Popularity of Minimally Invasive Procedures 3.2.3 Favorable Reimbursement Scenario would add to the Increased Acceptance of DBS Devices Globally 3.2.4 Availability of Technologically Advanced Deep Brain Stimulation Devices would Further Boost Market Growth 3.3 Market Restraints 3.3.1 Risks Associated with Deep Brain Stimulation Procedures 3.3.2 Implementation of Certain Government Policies such as the Affordable Care Act in the U.S. Negatively Affects the DBS Devices Market 5 Transparency Market Research

  6. Diabetes Device And Drugs Market 3.4 Market Opportunities 3.4.1 Address the High Unmet Needs of the Patient population in the Emerging Economies of the World 3.5 Porter’s Five Forces Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease 3.5.1 Bargaining Power of Suppliers 3.5.2 Bargaining Power of Buyers 3.5.3 Threat of Substitutes 3.5.4 Threat of New Entrants 3.5.5 Competitive Rivalry 3.6 Market Attractiveness Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography 3.7 Competitive Landscape 3.7.1 Market Share Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s disease, 2013 (Value %) Chapter 4 Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography 4.1 Overview 4.1.1 Global Prevalence of Parkinson’s Disease, by Geography, 2012 – 2020 (Number of Patients) 4.1.2 Global Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Geography, 2012 – 2020 4.1.3 Global Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Geography, 2012 – 2020 (USD Million) 4.2 North America 4.2.1 North America Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients) 4.2.2 North America Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020 4.2.3 North America Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million) 4.2.4 United States 4.2.4.1 United States Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million) 4.2.5 Canada 6 Transparency Market Research

  7. Diabetes Device And Drugs Market 4.2.5.1 Canada Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million) 4.3 Europe 4.3.1 Europe Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients) 4.3.2 Europe Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020 4.3.3 Europe Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million) 4.3.4 Germany 4.3.4.1 Germany Deep Brain Stimulation Devices Market for Parkinson’s Disease Revenue, 2012 – 2020 (USD Million) 4.3.5 Italy 4.3.5.1 Italy Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.3.6 Spain 4.3.6.1 Spain Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.3.7 United Kingdom 4.3.7.1 United Kingdom Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.3.8 France 4.3.8.1 France Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.3.9 Rest of Europe (RoE) 4.3.9.1 RoE Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4 Asia Pacific 4.4.1 Asia Pacific Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients) 4.4.2 Asia Pacific Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020 4.4.3 Asia Pacific Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million) 7 Transparency Market Research

  8. Diabetes Device And Drugs Market 4.4.4 Australia 4.4.4.1 Australia Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4.5 China 4.4.5.1 China Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4.6 India 4.4.6.1 India Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4.7 New Zealand 4.4.7.1 New Zealand Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4.8 Japan 4.4.8.1 Japan Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.4.9 Rest of APAC 4.4.9.1 Rest of APAC Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.5 Rest of the World (RoW) 4.5.1 RoW Prevalence of Parkinson’s Disease, by Country, 2012 – 2020 (Number of Patients) 4.5.2 RoW Number of Patients with Parkinson’s Disease Treated with Deep Brain Stimulation Devices, by Country, 2012 – 2020 4.5.3 RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, by Country, 2012 – 2020 (USD Million) 4.5.4 Brazil 4.5.4.1 Brazil Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.5.5 Mexico 4.5.5.1 Mexico Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) 4.5.6 Rest of RoW 8 Transparency Market Research

  9. Diabetes Device And Drugs Market 4.5.6.1 Rest of RoW Deep Brain Stimulation Devices for Parkinson’s Disease Market Revenue, 2012 – 2020 (USD Million) Chapter 5 Recommendations 5.1 Improved Product Life and Reduction in the Price of DBS Devices would Create Better Prospects for Players in this Market 5.2 Manufacturing of Deep Brain Stimulation Devices to be Outsourced to Contract Manufacturing Organizations 5.3 Target Emerging Economies of the World for Higher Benefits 5.4 Improve Public Awareness About the Disease, its Consequences as well as Treatment Options and Associated Benefits Chapter 6 Company Profiles 6.1 Aleva Neurotherapeutics SA 6.1.1 Company Overview 6.1.2 Financial Overview 6.1.3 Product Portfolio 6.1.4 Business Strategies 6.1.5 Recent Developments 6.2 Boston Scientific Corporation 6.2.1 Company Profile 6.2.2 Financial Overview 6.2.3 Product Portfolio 6.2.4 Business Strategies 6.2.5 Recent Developments 6.3 Medtronic, Inc. 6.3.1 Company Overview 6.3.2 Financial Overview 6.3.3 Product Portfolio 6.3.4 Business Strategies 9 Transparency Market Research

  10. Diabetes Device And Drugs Market 6.4 St. Jude Medical, Inc. 6.4.1 Company Profile 6.4.2 Financial Overview 6.4.3 Product Portfolio 6.4.4 Business Strategies Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : https://keshabblog.wordpress.com 10 Transparency Market Research

  11. Diabetes Device And Drugs Market 11 Transparency Market Research

More Related